Clinical Trials Browser

Unknown × Tyrosine Kinase Inhibitors × Myeloid × Clear all

NCT02687425 2016-02-22

SESPI

Phase 2 Unknown

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive